Jon Heyman talks to some MLB insiders and reports that, yes Virginia, suspensions are looming in the Biogenesis scandal:
Major League Baseball has started interviewing big leaguers linked to the Miami PED investigation, and people who have spoken to MLB investigators are convinced there will be at least some suspensions handed down in the explosive case.
This is just speculation on my part, but given that Heyman tends to be more plugged-in on the player/agent side, those “people who have spoken to MLB investigators” could very well be the lawyers and/or agents for players interviewed. Worth noting that, in my experience, when your client is interviewed by authorities of any type, they tend have a good sense of how much trouble they’re in.
So if suspensions are coming, that leads one to ask (a) when?; and (b) will it be public? For as Heyman also notes, one of the more interesting issues is whether or not MLB is obligated to keep the names of suspended players confidential pending their appeal. MLB believes that they don’t have to if the names have already been made public, many of which have here. The union believes, however, that per the Joint Drug Agreement, suspensions can only be announced after appeals have run their course.
My reading of the JDA supports the union side. But practicality suggests that keeping it confidential will be close to impossible due to the fact that the appeals here will involve multi-day and possibly multi-week hearings with players and lawyers going back and forth and into and out of office buildings on offdays or, quite possibly, game days. It’s gonna be known.
Anyway: brace yourselves. A circus is coming.
Former Tigers infielder Casey McGehee has reportedly signed a one-year deal with the Yomiuri Giants of Nippon Professional Baseball, according to FOX Sports’ Ken Rosenthal.
It’s the fourth move the corner infielder has made in the last two seasons after seeing short-term stints with the Marlins, Giants and Tigers. He signed a minor league deal with the Tigers prior to the 2016 season, providing the club with some infield depth behind 24-year-old Nick Castellanos. When Castellanos hit the disabled list in August with a broken hand, McGehee was recalled from Triple-A Toledo for a 30-game stint and slashed .228/.260/.239 with one extra-base hit in 96 PA. His career batting line (.258/.317/.384 over eight seasons) isn’t too shabby, but his age and a long history of knee injuries puts a damper on his potential.
McGehee last appeared in the NPB circuit in 2013, when he signed a one-year, $1.5 million deal with the Tohoku Rakuten Golden Eagles. He spent the bulk of his season at the hot corner, batting an impressive .292/.396/.515 with 28 homers in 590 PA and appearing in the Eagles’ first and only championship run to date.
The deal comes with a club option for 2018, Rosenthal reports, though no figure has been specified.
Free agent left-hander Rich Hill is rumored to be entertaining a three-year, $40+ million offer from the Dodgers, reports Peter Gammons. The Boston Globe’s Nick Cafardo corroborated the report, adding that Hill could receive somewhere between $46 and $48 million from his former team.
Hill, 36, pitched to a 2.12 ERA and 3.91 FIP in back-to-back stints with the Athletics and Dodgers in 2016. While a chronic case of blisters on his pitching hand limited the frequency of his starts, he still figures to be one of the most productive and noteworthy starting pitchers on the market this winter.
The Orioles, Yankees, Red Sox, Rangers and Astros have all been mentioned as potential suitors for the left-hander’s services, though Orioles’ GM Dan Duquette said the club has yet to make a play for Hill and ESPN’s Jim Bowden pointed out that the Red Sox are less involved in trade talks than other interested parties.